Skip to content

The effect of Aloe vera gel on menstrual pain

Evaluation the effect of oral Aloe vera gel on severity of primary dysmenorrhea in students of Zahedan University of Medical Sciences

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201206069957N1
Enrollment
80
Registered
2013-01-29
Start date
2011-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmenorrhea. Primary dysmenorrhea

Interventions

Intervention 1: The Aloe vera group took 1 tablespoon Aloe vera gel by oral three times per day from two days before and three days after the beginning of menstrual cycle for two consecutive cycles.
Treatment - Drugs
Placebo
The Aloe vera group took 1 tablespoon Aloe vera gel by oral three times per day from two days before and three days after the beginning of menstrual cycle for two consecutive cycles.
The placebo group took 1 tablespoon placebo gel by oral three times per day from two days before and three days after the beginning of menstrual cycle for two consecutive cycles.

Sponsors

Vice chancellor for Research and Technology, Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 25 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: being unmarried, having score 4 to 10 for dysmenorrhea according to pain scale, not known chronic diseases, having regular menstrual periods between 21 to 35 days, no history of myoma, pelvic tumor, andometriosis and pelvic inflammatory disease, no taking oral particular drug, no history of allergy to herbal drugs. Exclusion criteria: allergy to Aloe vera during intervention, incorrect taking the drug.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of primary dysmenorrhea. Timepoint: 3 menstrual cycles, one cycle before the study and 2 cycles during the study with 5 time intervals: first 2 hours from onset of menses, 2 to 12 hours, 12 to 24 hours, second day and third day of menstrual cycle. Method of measurement: verbal multidimensional scoring system and visual analogue scale.

Secondary

MeasureTime frame
Nausea. Timepoint: during first 3 days of the menstrual period and at the end of the menstrual period for 2 cycles of intervention. Method of measurement: Questionnaire (Yes, No).;Vomiting. Timepoint: during first 3 days of the menstrual period and at the end of the menstrual period for 2 cycles of intervention. Method of measurement: Questionnaire (Yes, No).;Diarrhea. Timepoint: during first 3 days of the menstrual period and at the end of the menstrual period for 2 cycles of intervention. Method of measurement: Questionnaire (Yes, No).;Headache. Timepoint: during first 3 days of the menstrual period and at the end of the menstrual period for 2 cycles of intervention. Method of measurement: Questionnaire (Yes, No).;Itching. Timepoint: during first 3 days of the menstrual period and at the end of the menstrual period for 2 cycles of intervention. Method of measurement: Questionnaire (Yes, No).;Hives. Timepoint: during first 3 days of the menstrual period and at the end of the menstrual period for 2 cycles of intervention. Method of measurement: Questionnaire (Yes, No).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdiye Donyadari

Zahedan University of Medical Sciences

m_20282000@yahoo.com+98 54 1243 8473

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026